Administration of Noggin Suppresses Fibrinogen Leakage into the Brain in the Acute Phase After Traumatic Brain Injury in Mice
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26073002 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Miho Yasunaga und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Care and Health Sciences, Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka 814-0180, Japan. Hauptthemen laut MEDLINE: Brain Injuries, Traumatic, Fibrinogen, Carrier Proteins, Brain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, CENTRAL RESEARCH INSTITUTE OF FUKUOKA UNIVERSITY.
Abstract (Originalsprache)
Traumatic brain injury (TBI) causes neurovascular unit (NVU) dysfunction, including hyperpermeability of the blood–brain barrier to fibrinogen, glial activation, and neuronal damage, possibly leading to secondary brain damage. However, no known substance can inhibit its pathogenesis. In this study, we investigated noggin, a bone morphogenetic protein (BMP) 4 inhibitor, as a TBI pathogenesis-inhibiting substance. We induced acute TBI in C57BL/6J mice through a controlled cortical impact (CCI) and evaluated the effects of noggin on fibrinogen leakage into the brain and NVU-constituting cells, including pericytes, microglia, astrocytes, and neurons. CCI mice showed increased BMP4 levels and extravascular fibrinogen in the hippocampus. Noggin treatment significantly suppressed fibrinogen leakage four days post-CCI in a dose-dependent manner. Immunofluorescence staining revealed that noggin administration did not inhibit the activation of NVU cells such as pericytes, microglia, and astrocytes, which were characterized by increased PDGFRβ, Iba1, and GFAP expression levels, respectively. On postoperative day 4, CCI mice showed neuronal cell and myelinated neuronal fiber loss, which were not significantly affected by noggin administration. In conclusion, noggin administration suppresses fibrinogen leakage into the brain in the acute phase after TBI. However, the suppression of fibrinogen leakage through noggin administration did not alleviate neuronal damage and activation of NVU cells during the acute phase of TBI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Care and Health Sciences, Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka 814-0180, Japan.
ORCID-Profile: Fuyuko Takata, Takuro Iwao, Shinya Dohgu
Förderung
- Japan Society for the Promotion of Science
- CENTRAL RESEARCH INSTITUTE OF FUKUOKA UNIVERSITY
Zitieren
APA
Yasunaga, M., Takata, F., Iwao, T., Mizoguchi, J., Tajima, N., & Dohgu, S. (2025). Administration of Noggin Suppresses Fibrinogen Leakage into the Brain in the Acute Phase After Traumatic Brain Injury in Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26073002
Vancouver
Yasunaga M, Takata F, Iwao T, Mizoguchi J, Tajima N, Dohgu S. Administration of Noggin Suppresses Fibrinogen Leakage into the Brain in the Acute Phase After Traumatic Brain Injury in Mice. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26073002
BibTeX
@article{Yasunaga2025,
author = {Yasunaga, Miho and Takata, Fuyuko and Iwao, Takuro and Mizoguchi, Junko and Tajima, Nanako and Dohgu, Shinya},
title = {Administration of Noggin Suppresses Fibrinogen Leakage into the Brain in the Acute Phase After Traumatic Brain Injury in Mice},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26073002}
}
EUVIMED